Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (233)

2024

  1. Clinical profile, management and outcomes of patients with cardiogenic shock undergoing transfer between centers in Spain

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 226-233

  2. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

  3. Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Cardiorenal benefits of finerenone: protecting kidney and heart

    Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513

  3. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  4. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

    European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202

  5. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  6. First-Pass Effect in M1-Occlusion Stroke Patients Treated with Combined Stent-Retriever/Large-Bore Distal Aspiration Catheter Thrombectomy

    Clinical Neuroradiology, Vol. 33, Núm. 3, pp. 701-708

  7. Has the Reduction in Tobacco Consumption in Spain Stopped? No, But We Have to Speed It Up

    Archivos de Bronconeumologia

  8. Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 7, pp. 422-429

  9. Impact of shock aetiology and hospital characteristics on the clinical profile, management and prognosis of patients with non ACS-related cardiogenic shock

    Hellenic Journal of Cardiology, Vol. 69, pp. 16-23

  10. Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 305-310

  11. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat

    Patient Preference and Adherence, Vol. 17, pp. 839-849

  12. RECALCAR methodology. Some clarifications

    Revista Espanola de Cardiologia

  13. SEED Consensus Document on SpyGlass-DS

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 1, pp. 69-79

  14. The three-noes right-sided infective endocarditis: An unrecognized type of right-sided endocarditis

    Medicine, Vol. 102, Núm. 29, pp. e34322

  15. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 3, pp. 679-687

  2. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    European Respiratory Journal